M RE4 (Ropinirole Hydrochloride Extended-Release 4 mg)
Pill with imprint M RE4 is Brown, Round and has been identified as Ropinirole Hydrochloride Extended-Release 4 mg. It is supplied by Mylan Pharmaceuticals Inc.
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M RE4
Ropinirole Hydrochloride Extended-Release
- Imprint
- M RE4
- Strength
- 4 mg
- Color
- Brown
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-4091 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
ferrosoferric oxide,
silicon dioxide,
ethylcellulose,
FD&C Red No. 40,
FD&C Yellow No. 6,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
propylene glycol,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Related Images for "M RE4"
More about ropinirole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (308)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Ropinirole (Advanced Reading)
- Ropinirole Extended-Release Tablets
- Ropinirole Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.